Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
A to Z Index
Follow FDA
FDA Voice Blog
Enter Search terms
Most Popular Searches
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
New Pediatric Labeling Information Database - Detail
FDA Home
Pediatrics
New Pediatric Labeling Information Database
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Pediatric Labeling Date:
01/23/2008
Trade Name:
Moxatag
Generic Name or Proper Name (*):
amoxicillin
Indications Studied:
Use for tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes patients 12 years of age and older
Label Changes Summary:
* Safety and effectiveness in pediatric patients younger than 12 years have not been established * One clinical study evaluated safety and effectiveness in pediatric patients 12 years of age and older with no significant differences in treatment response or adverse reactions between adults and children * A prospective study of 51 children suggested that overdosages of less than 250 mg/kg are not associated with significant clinical symptoms and do not require gastric emptying * Waiver of studies in children ages 0 to less than two years because too few children have the disease * New dosage form
Product Labeling:
Labeling
PREA(P):
P
Sponsor:
Middlebrook Pharmaceuticals
NNPS:
FALSE
Therapeutic Category:
Antibiotic
-
-